Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ryusuke Shodo

5PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)ClinimetricsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

Sort by Publication Date:
|Jul 01, 2026
Feasibility and preliminary effects of combined exercise and nutritional intervention on muscle mass preservation during chemoradiotherapy for head and neck cancer: a prospective study.

|Jul 12, 2025
Oropharyngeal candidiasis during radiotherapy for head and neck cancer: an observational study on prevalence, pain, and risk factors.

Ryusuke Shodo, Yushi Ueki, Kouji Katsura

|Dec 09, 2023
Sarcopenia Index Predicts Short-Term Prognosis of Head and Neck Squamous Cell Carcinoma.

Ryusuke Shodo, Keisuke Yamazaki, Yushi Ueki

|Aug 11, 2020
Sarcopenia predicts a poor treatment outcome in patients with head and neck squamous cell carcinoma receiving concurrent chemoradiotherapy.

Ryusuke Shodo, Keisuke Yamazaki, Yushi Ueki

|Jul 17, 2020
Role of programmed death-ligand 1 in predicting the treatment outcome of salvage chemotherapy after nivolumab in recurrent/metastatic head and neck squamous cell carcinoma.

Yushi Ueki, Takeshi Takahashi, Hisayuki Ota

Pageof 1

Frequent Collaborators

1 joint publications

Yushi Ueki

1 joint publications

Takeshi Takahashi

Frequent Collaborators

1 joint publications

Yushi Ueki

1 joint publications

Takeshi Takahashi